INDOCO REMEDIES LIMITED
Location
Maharashtra
Founded
1947-08-23
Website
Risk Signals
87 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Medicinal Chemicals and Botanical Products, Pharmaceutical Preparations), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about INDOCO REMEDIES LIMITED
Live alerts from global media, monitored by Business Radar
(economictimes.com)
Indoco Remedies gets warning letter from USFDA for Goa plant -
Indoco Remedies' Goa plant received a warning letter from the USFDA following a July inspection. The company stated its commitment to resolving the issues and maintaining compliance with US regulations while continuing to supply products to the US market. The company's shares saw a slight increase despite the warning.
Read more
(fiercepharma.com)
FDA issues warning for sterile drugmaker after 1,500 customer complaints |
The other regulatory shoe has dropped for India's Indoco Remedies, which has had a sterile injectables plant blasted in an FDA warning letter for its laissez-faire approach to dealing with the hund | India's Indico Remedies has had a sterile injectables plant blasted in an FDA warning letter for its laissez-faire approach to dealing with the hundreds of consumer complaints it receives each year.
Read more
(biospectrumindia.com)
Indoco Remedies receives FDA nod for gout medication
Febuxostat is used for the treatment of gout caused by excessive levels of uric acid in the blood (Hyperuricemia)
Read more
(equitybulls.com)
Indoco's Clinical Research Organisation - AnaCipher completes US FDA inspection |
Indoco Remedies Limited announced today that its Clinical Research Organisation, AnaCipher, located at Hyderabad, has completed its 5-day comprehensive USFDA inspection.
Read more
(freepressjournal.in)
Indoco Remedies Gets USFDA Nod To Market Generic Diabetes Drug
The company has received tentative approval from the US Food and Drug Administration (USFDA) for abbreviated new drug application (ANDA) for Canagliflozin and Metformin Hydrochloride tablets in various strengths, Indoco Remedies said in a regulatory filing.
Read more
(indiatimes.com)
Indoco Remedies gets USFDA nod for schizophrenia, bipolar disorder treatment drug - ET HealthWorld | Pharma
In a BSE filing, Indoco Remedies announced receipt of approval for its abbreviated new drug application (ANDA) for Olanzapine Tablets USP in the strengths of 2.5mg, 5mg, 7.5 mg, 10mg, 15mg and 20 mg.
Read more
(indiatimes.com)
Establishment Inspection Report: Indoco Remedies receives EIR from US FDA for Goa facility, ET HealthWorld
Establishment Inspection Report: The company has received an EIR with Voluntary Action Indicated (VAI) status from USFDA for its facility for solid dosages (Plant I) located in Verna, Goa, Indoco Remedies said in a regulatory filing. As per USFDA, a VAI means that objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
Read more
(medicaldialogues.in)
USFDA inspection: Indoco Remedies gets 9 observations for Goa facility
Mumbai: Indoco Remedies has announced that the United States Food and Drug Administration (USFDA) has issued 9 observations after GMP inspection at the Solid Oral Formulation Facility (Plant 1) at...
Read more
(medicaldialogues.in)
Indoco Remedies clinical research organisation AnaCipher gets UK MHRA accreditation
Mumbai: Indoco Remedies Ltd. has recently announced the receipt of GCP & GLP accreditation from the UK-MHRA (Medicines and Healthcare Products Regulatory Agency) for its Clinical Research...
Read more
(medicaldialogues.in)
Indoco Remedies Baddi facility gets GMP certification from EU Health Authority
Mumbai: Indoco Remedies has received EU GMP certification from the Competent Health Authority of Malta for its manufacturing site in Baddi (Unit -I) located at Village Katha, Tehsil- Nalagarh,...
Read more
(economictimes.com)
Teva launches Indoco Remedies-developed generic drug in US -
The product, which is a generic version of Azopt ophthalmic suspension, is developed and manufactured by the Mumbai-based drug firm at its Goa facility for Teva.
Read more